FGFR4 and cervical carcinoma: FGFR4 rs1966265 changes chemotherapy response in breast cancer [62], higher risk of oral squamous cell carcinoma susceptibility [31], initiation of cervical cancer (Taiwanese women) [19], and higher risk of breast cancer in Chinese women of Heilongjiang province [16].